Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mid-Atlantic Diamond Ventures is an active U.S.-based venture forum and business development platform focused on helping early-stage, technology-based startups become investor-ready. The organization connects founders with experienced advisors, angel investors, venture capitalists, and business leaders, and appears to operate as part of Temple University's innovation ecosystem. Its scope spans multiple sectors including information technology, physical technology, medical devices, biotechnology, and other innovation-driven businesses, rather than functioning as a single therapeutic-product company. For life science analysts, MADV is best understood as a startup support and venture network organization that may include healthcare and biotech companies in its portfolio, not as a drug developer itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mid-Atlantic Diamond Ventures.